BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12908492)

  • 1. Pneumonitis and non steroidal antiandrogens.
    Prescrire Int; 2003 Aug; 12(66):141. PubMed ID: 12908492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect.
    Bennett CL; Raisch DW; Sartor O
    Ann Intern Med; 2002 Oct; 137(7):625. PubMed ID: 12353966
    [No Abstract]   [Full Text] [Related]  

  • 3. Bicalutamide-associated fulminant hepatic failure.
    Chodak GW
    Urology; 1997 Dec; 50(6):1027. PubMed ID: 9426744
    [No Abstract]   [Full Text] [Related]  

  • 4. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system.
    Manso G; Thole Z; Salgueiro E; Revuelta P; Hidalgo A
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):253-9. PubMed ID: 16294367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications of antiandrogens in benign hyperplasia of the prostate].
    Benassayag E
    J Urol (Paris); 1995; 101(2):109-10. PubMed ID: 8522854
    [No Abstract]   [Full Text] [Related]  

  • 6. Fulminant hepatic failure associated with bicalutamide.
    Schellhammer PF
    Urology; 1997 Nov; 50(5):827. PubMed ID: 9372905
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
    Urushibara M; Ishioka J; Hyochi N; Kihara K; Hara S; Singh P; Isaacs JT; Kageyama Y
    Prostate; 2007 Jun; 67(8):799-807. PubMed ID: 17373727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximal androgen blockade for advanced prostate cancer.
    Klotz L
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):331-40. PubMed ID: 18471790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
    Sakai H; Igawa T; Tsurusaki T; Yura M; Kusaba Y; Hayashi M; Iwasaki S; Hakariya H; Hara T; Kanetake H
    Urology; 2009 Mar; 73(3):635-40. PubMed ID: 19038426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy.
    Davis NB; Ryan CW; Stadler WM; Vogelzang NJ
    BJU Int; 2005 Oct; 96(6):787-90. PubMed ID: 16153201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary toxicity of nilutamide (Anandron). Cooperative evaluation of French Regional Pharmacovigilance Centers].
    Jonville AP; Diot E; Dutertre JP; Autret E
    Therapie; 1992; 47(5):393-7. PubMed ID: 1299978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?
    Ramsey S; Veenstra D; Clarke L; Gandhi S; Hirsch M; Penson D
    Urology; 2005 Oct; 66(4):835-9. PubMed ID: 16230148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiandrogen withdrawal syndrome with nilutamide.
    Gomella LG; Ismail M; Nathan FE
    J Urol; 1997 Apr; 157(4):1366. PubMed ID: 9120950
    [No Abstract]   [Full Text] [Related]  

  • 15. Flutamide photosensitivity.
    Tsien C; Souhami L
    J Urol; 1999 Aug; 162(2):494. PubMed ID: 10411069
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of male breast cancer in association with bicalutamide-induced gynaecomastia.
    Chianakwalam CI; McCahy P; Griffiths NJ
    Breast; 2005 Apr; 14(2):163-4. PubMed ID: 15767188
    [No Abstract]   [Full Text] [Related]  

  • 17. Flutamide induced methemoglobinemia.
    Khan AM; Singh NT; Bilgrami S
    J Urol; 1997 Apr; 157(4):1363. PubMed ID: 9120948
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effectiveness of luteinizing hormone-releasing hormone agonist or antiandrogen monotherapy in elderly men with localized prostate cancer (T1-2): a retrospective study.
    Raina R; Pahalajani G; Agarwal A; Zippe C
    Asian J Androl; 2007 Mar; 9(2):253-8. PubMed ID: 17334592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression.
    Fuse H; Korenaga S; Sakari M; Hiyama T; Ito T; Kimura K; Kato S
    Prostate; 2007 May; 67(6):630-7. PubMed ID: 17342748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fatal fulminating hepatitis caused by nilutamide. A new case].
    Marty F; Godart D; Doermann F; Mérillon H
    Gastroenterol Clin Biol; 1996; 20(8-9):710-1. PubMed ID: 8977826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.